Axon Enterprise, Inc $AXON Shares Sold by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP decreased its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 7.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 729,152 shares of the biotechnology company’s stock after selling 60,927 shares during the period. Axon Enterprise makes up 2.2% of Westfield Capital Management Co. LP’s holdings, making the stock its 9th largest position. Westfield Capital Management Co. LP owned 0.92% of Axon Enterprise worth $523,269,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Stone House Investment Management LLC bought a new stake in Axon Enterprise in the third quarter valued at about $29,000. New Millennium Group LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth about $29,000. Root Financial Partners LLC bought a new stake in shares of Axon Enterprise in the 3rd quarter valued at about $34,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $37,000. Finally, NewSquare Capital LLC raised its position in shares of Axon Enterprise by 96.2% in the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after acquiring an additional 25 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. TD Cowen reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, November 5th. Barclays decreased their price target on shares of Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a report on Wednesday. Wall Street Zen downgraded Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Royal Bank Of Canada reduced their target price on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a research note on Tuesday, January 6th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus price target of $762.93.

Insiders Place Their Bets

In other news, President Joshua Isner sold 20,000 shares of the firm’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $552.60, for a total value of $11,052,000.00. Following the completion of the transaction, the president owned 249,502 shares in the company, valued at $137,874,805.20. This trade represents a 7.42% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Jennifer H. Mak sold 1,134 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $600.00, for a total value of $680,400.00. Following the sale, the chief accounting officer owned 13,740 shares in the company, valued at $8,244,000. The trade was a 7.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 48,040 shares of company stock valued at $27,249,338 in the last quarter. Company insiders own 4.40% of the company’s stock.

Key Headlines Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 beat and strong guidance — Axon reported Q4 revenue of ~$797M (+39% YoY) and non‑GAAP EPS $2.15, beating Street estimates; management issued FY26 growth guidance and a 2028 target of $6B in revenue, supporting upside expectations. PR Newswire: Axon reports Q4 2025
• Positive Sentiment: AI is accelerating demand — Management highlighted AI features across devices and software (body cams, evidence management, report drafting), which investors interpreted as boosting SaaS adoption and bookings momentum. Coverage noting the “AI supercharge” reaction: Investopedia: Axon AI story
• Positive Sentiment: Bookings/backlog and retention — Management disclosed a sizable increase in contracted bookings/backlog and a high net revenue retention (~125%), signaling both strong new sales and upsells from existing customers. This underpins longer‑term revenue visibility. MarketBeat: Q4 results & guidance deck
• Neutral Sentiment: Earnings call/transcript available — Investors can review management commentary and Q&A for nuance on federal spending, enterprise demand and AI rollout. Seeking Alpha: Q4 2025 transcript
• Neutral Sentiment: Short‑interest data flagged as anomalous — a February short‑interest entry shows 0 shares / NaN change (likely a reporting error); not meaningful for positioning until clarified.
• Negative Sentiment: Analysts trimmed price targets despite the beat — several firms cut PTs (UBS to $570/neutral; Barclays, Morgan Stanley, Piper reduced PTs but kept overweight views in many cases), which could cap upside and reflect lingering valuation/near‑term risk concerns. Benzinga: analyst PT cuts

Axon Enterprise Trading Up 17.6%

NASDAQ AXON opened at $520.18 on Thursday. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12. The stock’s 50 day moving average price is $539.22 and its two-hundred day moving average price is $628.00. The stock has a market capitalization of $41.05 billion, a price-to-earnings ratio of 342.23, a PEG ratio of 13.33 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.94%. The firm’s revenue was up 38.5% compared to the same quarter last year. During the same period last year, the company earned $2.08 earnings per share. As a group, analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.